Evidence map›Paper›PMID 41131872›Full record

ArticleAngewandte Chemie (International ed. in English)2025

Three-Segment Protein Labeling Using a Highly Efficient and Cysteine-Less Split Intein Identified with Computational Prediction of Aggregation Properties.

Christoph Humberg, Jonas Kröger, Shmuel Pietrokovski, Henning D Mootz

Abstract read
In one paragraph

Article in Angewandte Chemie (International ed. in English), 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Christoph Humberg *Department of Chemistry and Pharmacy, Institute of Biochemistry, University of Münster, Corrensstraße 36, 48149, Münster, Germany.ORCID 0000-0003-3394-9338
Jonas Kröger *Department of Chemistry and Pharmacy, Institute of Biochemistry, University of Münster, Corrensstraße 36, 48149, Münster, Germany.
Shmuel PietrokovskiDepartment of Molecular Genetics, Weizmann Institute of Science, Rehovot, 76100, Israel.
Henning D MootzDepartment of Chemistry and Pharmacy, Institute of Biochemistry, University of Münster, Corrensstraße 36, 48149, Münster, Germany.ORCID 0000-0002-3385-0234

Funding

Crown Human Genome CenterDeutsche Forschungsgemeinschaft DFG MO1073/8-2Deutsche Forschungsgemeinschaft DFG MO1073/9-1
6 · The paper itself

Abstract

Split inteins are versatile tools in protein engineering. We envisaged a new tandem protein trans-splicing (PTS) scheme to assemble a protein from three segments, of which each can be individually treated with regard to its cysteine oxidation or chemical labeling status. However, only a single highly efficient cysteine-less split intein has been reported so far. Split intein activities are currently not predictable and require time-consuming biochemical characterizations. We aimed to accelerate the discovery of novel split inteins with high splicing efficiency by computational sequence analysis. Inspired by our previous finding that linked reduced splicing efficiency of characterized split intein fragments to soluble, β-sheet-rich amyloid-like aggregates, we confirmed the inverse correlation between predicted aggregation propensity and splicing efficiency for new intein candidates by size-exclusion chromatography and biochemical analysis. The LCGC14 intein emerged as a second available cysteine-less split intein with virtually quantitative splicing efficiency, significantly expanding protein engineering opportunities independent of thiol chemistries or in oxidizing conditions. We exploit the orthogonality to the cysteine-less CLm intein to assemble proteins from three selectively labeled segments, as demonstrated for a trimodular non-ribosomal peptide synthetase (NRPS). The prediction of split intein efficiency from their sequence is a significant advancement to streamline future discovery processes.

Indexed as

CysteineInteinsProteinsProtein AggregatesProtein EngineeringProtein SplicingCysteineProtein AggregatesProteinsClick biologyProtein labelingProtein ligationProtein splicingThiol bioconjugation

Identifiers

PMID41131872
PMCPMC12707363

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.